Company news

Codexis, Inc. news in 2022

Codexis, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Codexis Announces Appointment of H. Stewart Parker to Board of Directors

December 19, 2022

Codexis Provides Update on Prioritized Corporate Strategy

November 28, 2022

Codexis to Participate in Piper Sandler 34th Annual Healthcare Conference

November 15, 2022

Codexis Reports Third Quarter 2022 Financial Results

November 2, 2022

Codexis Announces Appointment of Margaret Fitzgerald as Chief Legal Officer and General Counsel

October 31, 2022

Codexis to Report Third Quarter 2022 Financial Results on November 3

October 19, 2022

Codexis Announces Appointment of Rahul Singhvi, Sc.D., to Board of Directors

October 2, 2022

Codexis Announces Appointment of Kevin Norrett as Chief Operating Officer

October 2, 2022

Codexis’ 2022 Protein Engineering Forum Showcases Recent Industry Success and Emerging Innovations in the Field

September 13, 2022

Codexis Reports Second Quarter 2022 Financial Results

August 3, 2022

Codexis and Molecular Assemblies Announce Execution of Commercial License and Enzyme Supply Agreement for Optimized TdT Enzyme for Enzymatic DNA Synthesis

August 1, 2022

Codexis Announces CEO Transition Effective August 9, 2022

July 17, 2022

Codexis Announces Preliminary Second Quarter 2022 Results and Updates Guidance

July 13, 2022

Codexis Announces Agreement with Pfizer to Supply Enzyme for the Manufacture of PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)

July 13, 2022

Codexis Announces the Publication of Research Demonstrating Proof of Concept for Chemoenzymatic Site-Selective Bioconjugation of Native Peptides

June 16, 2022

Codexis Presents Pre-Clinical Data Highlighting Gene Therapy Programs at the ASGCT 25th Annual Meeting

May 15, 2022

Codexis Reports First Quarter 2022 Financial Results

May 4, 2022

Codexis to Present Data Highlighting Three Gene Therapy Programs at the ASGCT 25th Annual Meeting

May 1, 2022

Codexis to Report First Quarter 2022 Financial Results on May 5

April 20, 2022

Codexis and seqWell Announce Strategic Investment and Partnership Initiation

April 20, 2022

Codexis and Molecular Assemblies Announce Results of First Collaboration on a Proprietary High Performing DNA Polymerase to Supercharge Fully Enzymatic DNA Synthesis

April 11, 2022

Codexis to Participate in the Cowen 42nd Annual Health Care Conference

February 28, 2022

Codexis Reports Fourth Quarter and Fiscal Year 2021 Financial Results

February 23, 2022

Codexis to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 24

February 9, 2022

Codexis Announces FDA Orphan Drug and Rare Pediatric Disease Designations for CDX 6512 for the Treatment of Homocystinuria

January 23, 2022

Codexis to Participate in the H.C. Wainwright Virtual BioConnect Conference

January 4, 2022

Calls in 2022

Decks in 2022